Tonix Pharmaceuticals Announces Research Agreement with University of Maryland Baltimore to Study TNX-1500 for the Prevention of Rejection in Heart Xenograft Transplantation in Animals
Tonix Pharmaceuticals Holding Corp. , a clinical-stage biopharmaceutical company, today announced that it has entered into a sponsored research agreement with the University of Maryland, Baltimore ,... | February 2, 2023
United States Muhammadm Mohiuddin Seth Lederman Tonix Pharmaceuticals University Of Maryland Revivicor Inc
Source: marketscreener.com